Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CACNA1C antisense RNA 4 (CACNA1C-AS4) is a human long non-coding RNA (lncRNA) gene located on chromosome 12. It is classified as a non-protein coding RNA and belongs to the class of antisense RNAs because its sequence is complementary to a region of the CACNA1C gene, which encodes a voltage-gated calcium channel subunit[2][7]. CACNA1C-AS4 has at least two transcript isoforms but does not code for any protein product[2][7]. Its specific biological function, roles in disease, and value as a therapeutic target or biomarker remain currently unknown, and there are no known drugs, mechanisms of action, or associated safety concerns documented in public data[2][7]. There is no evidence supporting its classification as a therapeutic target such as a receptor, enzyme, transporter, or similar[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CACNA1C antisense RNA 4 (CACNA1C-AS4).